Cleerly COMPARE

How can serial cardiac CTs with Cleerly support prognosis?

In our twelfth Transforming Cardiac Care webinar, preventive cardiologist Matthew Budoff, MD, MSCCT, examines the value of coronary computed tomography angiography (CCTA) with Cleerly COMPARE for evaluating atherosclerosis, the root cause of coronary artery disease.

Cleerly’s COMPARE tool simplifies how providers measure disease progression with a side-by-side comparison of plaque volume, including changes in calcified and non-calcified plaque. Changes across lesions and vessels are illustrated in a digital analysis and summarized to help providers make calculated treatment decisions.

Attendees can expect to learn how the insights of advanced plaque analysis with machine learning algorithms can aid treatment and see how the Cleerly COMPARE tool can enhance the use of serial CCTA for tracking disease progression.

Dr. Budoff’s presentation will conclude with a Q&A session, open to all attendees.

Our Key Panelists

Matthew Budoff, MD, MSCCT
Preventive Cardiologist and Professor of Medicine, David Geffen School of Medicine

Dr. Budoff is a professor of medicine at David Geffen School of Medicine at UCLA and the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center.

Dr. Budoff serves as a paid consultant for Cleerly. His views are based on his personal expertise and research.

 

James P. Earls, MD
Chief Medical Officer, Cleerly Inc.

Dr. Earls is a Professor of Radiology at George Washington University Hospital and a leader within the field of Radiology in applications of advanced imaging technologies in cardiovascular care.